Multiplexed
diagnostics refer to equipment that are used for analyzing multiple analytes in
the single cycle of the assay procedure. Multiplexed diagnostics can diagnose
and run multiple tests on a specimen. These tools are evolved from diagnostic
assays that screen a single analyte in a single run of the assay procedure.
Multiplexed diagnostics find their use in research laboratories and diagnostics
laboratories. Research and development laboratories use multiplexed assays in
drug development procedures to screen multiple analytes. Multiplexed
diagnostics are used in various fields such as drugs-abuse screening,
pharmacogenetics, and infection testing.
Analysts forecast
the Global Multiplexed
Diagnostics market to grow at a
CAGR of 20.05 percent over the period 2013-2018.
The report
recognizes the following companies as the key players in the Global Multiplexed
Diagnostics Market: Affymetrix Inc., Agilent Technologies, bioMérieux SA, F.
Hoffmann-La Roche, Illumina Inc. and Thermo Fisher Scientific.
Other Prominent
Vendors in the market are: Abbott Laboratories, Becton Dickinson, Bio-Rad
Laboratories, Cepheid, Hologic, Luminex, Qiagen and Siemens Healthcare.
Expanding economies
in the Asia Pacific region is a major trend in the market. The governments in
emerging countries are making efforts to improve the healthcare infrastructure,
which has benefited the Global Multiplexed Diagnostics market.
Get discount on the
Report @ http://www.sandlerresearch.org/discount?rname=25194
.
Covered in this Report
The Global
Multiplexed Diagnostics market can be segmented into revenue generated from
various multiplexed diagnostics technologies such as: Medium Density
Multiplexed Assays, Low Density Multiplexed Assays, High Density Multiplexed
Assays, Very High Density Multiplexed Assays and Next-Generation Sequencing.
Global Multiplexed
Diagnostics Market 2014-2018, has been prepared based on an in-depth market
analysis with inputs from industry experts. The report covers the Americas, and
the EMEA and APAC regions; it also covers the Global Multiplexed Diagnostics
market landscape and its growth prospects in the coming years. The report also
includes a discussion of the key vendors operating in this market.
According to the
report, one of the major drivers in the market is an increase in technological
innovations to provide efficient and inexpensive devices to diagnose and treat
diseases. Advances in technology and innovations in the Healthcare industry
have resulted in the development of equipment customized to the needs of
patients.
Further, the report
states that accurate diagnostic testing and the rate of false positive and
false negative results are the major issues in the market. The rate of false
positive and false negative results, which mostly occur during the window
period, is a major challenge to the Global Multiplexed Diagnostics market.
Single User License
of the Report is Available at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=25194 .
